Parasitic Sensitivity Tests

"Parasitic Sensitivity Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tests that demonstrate the relative effectiveness of chemotherapeutic agents against specific parasites.

Descriptor ID	D021261
MeSH Number(s)	E01.370.225.940 E05.200.940 E05.337.550.700
Concept/Terms	Parasitic Sensitivity Tests Parasitic Sensitivity Tests Parasitic Sensitivity Test Sensitivity Test, Parasitic Test, Parasitic Sensitivity Tests, Parasitic Sensitivity Parasite Sensitivity Tests Parasite Sensitivity Test Sensitivity Test, Parasite Sensitivity Tests, Parasite Test, Parasite Sensitivity Tests, Parasite Sensitivity Drug Sensitivity Tests, Parasitic Protozoal Drug Sensitivity Tests Protozoal Drug Sensitivity Tests Protozoa Drug Sensitivity Tests Drug Sensitivity Tests, Protozoal Helminth Drug Sensitivity Tests Helminth Drug Sensitivity Tests Drug Sensitivity Tests, Helminth

Below are MeSH descriptors whose meaning is more general than "Parasitic Sensitivity Tests".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Diagnosis [E01]
Diagnostic Techniques and Procedures [E01.370]
Clinical Laboratory Techniques [E01.370.225]
Parasitic Sensitivity Tests [E01.370.225.940]
Investigative Techniques [E05]
Clinical Laboratory Techniques [E05.200]
Parasitic Sensitivity Tests [E05.200.940]
Evaluation Studies as Topic [E05.337]
Drug Evaluation, Preclinical [E05.337.550]
Parasitic Sensitivity Tests [E05.337.550.700]

Below are MeSH descriptors whose meaning is more specific than "Parasitic Sensitivity Tests".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Parasitic Sensitivity Tests" by people in this website by year, and whether "Parasitic Sensitivity Tests" was a major or minor topic of these publications.

Bar chart showing 11 publications over 9 distinct years, with a maximum of 2 publications in 2024 and 2025

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2005	0	1	1
2010	0	1	1
2013	0	1	1
2015	0	1	1
2016	0	1	1
2018	0	1	1
2020	0	1	1
2024	1	1	2
2025	0	2	2

Below are the most recent publications written about "Parasitic Sensitivity Tests" by people in Profiles.

Okitwi M, Orena S, Tumwebaze PK, Katairo T, Taremwa Y, Byaruhanga O, Tukwasibwe S, Nsobya SL, Legac J, Bailey JA, Cooper RA, Conrad MD, Rosenthal PJ. Changes in susceptibility of Plasmodium falciparum to antimalarial drugs in Uganda over time: 2019-2024. Nat Commun. 2025 Aug 09; 16(1):7353.

View in: PubMed
Rosado J, Fola AA, Cojean S, Sarrasin V, Copp?e R, Bailly J, Zaffaroulah R, Bouzayene A, Cic?ron L, Houz? L, Crudale R, Musset L, Thellier M, Pradines B, Clain J, Bailey JA, Houz? S. Assessment of ex vivo antimalarial drug efficacy in African Plasmodium falciparum parasite isolates, 2016-2023: a genotype-phenotype association study. EBioMedicine. 2025 Aug; 118:105835.

View in: PubMed
Okitwi M, Shoue DA, Checkley LA, Orena S, Ceja FG, Taremwa Y, Tumwebaze PK, Katairo T, Byaruhanga O, Sievert MA, Garg S, Kreutzfeld OK, Legac J, Bailey JA, Nsobya SL, Conrad MD, Rosenthal PJ, Ferdig MT, Cooper RA. The extended recovery ring-stage survival assay is a scalable alternative for artemisinin susceptibility phenotyping of fresh Plasmodium falciparum isolates. Antimicrob Agents Chemother. 2024 12 05; 68(12):e0118324.

View in: PubMed
Kreutzfeld O, Orena S, Okitwi M, Tumwebaze PK, Byaruhanga O, Katairo T, Conrad MD, Legac J, Garg S, Crudale R, Aydemir O, Giesbrecht D, Nsobya SL, Blasco B, Duffey M, Rouillier M, Bailey JA, Cooper RA, Rosenthal PJ. Ex vivo susceptibilities to ganaplacide and diversity in potential resistance mediators in Ugandan Plasmodium falciparum isolates. Antimicrob Agents Chemother. 2024 09 04; 68(9):e0046624.

View in: PubMed
Mensah BA, Aydemir O, Myers-Hansen JL, Opoku M, Hathaway NJ, Marsh PW, Anto F, Bailey J, Abuaku B, Ghansah A. Antimalarial Drug Resistance Profiling of Plasmodium falciparum Infections in Ghana Using Molecular Inversion Probes and Next-Generation Sequencing. Antimicrob Agents Chemother. 2020 03 24; 64(4).

View in: PubMed
Tyagi R, Maddirala AR, Elfawal M, Fischer C, Bulman CA, Rosa BA, Gao X, Chugani R, Zhou M, Helander J, Brindley PJ, Tseng CC, Greig IR, Sakanari J, Wildman SA, Aroian R, Janetka JW, Mitreva M. Small Molecule Inhibitors of Metabolic Enzymes Repurposed as a New Class of Anthelmintics. ACS Infect Dis. 2018 07 13; 4(7):1130-1145.

View in: PubMed
Obald?a N, Dow GS, Gerena L, Kyle D, Otero W, Mantel PY, Baro N, Daniels R, Mukherjee A, Childs LM, Buckee C, Duraisingh MT, Volkman SK, Wirth DF, Marti M. Altered drug susceptibility during host adaptation of a Plasmodium falciparum strain in a non-human primate model. Sci Rep. 2016 Feb 16; 6:21216.

View in: PubMed
Wu CC, Hu Y, Miller M, Aroian RV, Sailor MJ. Protection and Delivery of Anthelmintic Protein Cry5B to Nematodes Using Mesoporous Silicon Particles. ACS Nano. 2015 Jun 23; 9(6):6158-67.

View in: PubMed
Hu Y, Ellis BL, Yiu YY, Miller MM, Urban JF, Shi LZ, Aroian RV. An extensive comparison of the effect of anthelmintic classes on diverse nematodes. PLoS One. 2013; 8(7):e70702.

View in: PubMed
Hu Y, Platzer EG, Bellier A, Aroian RV. Discovery of a highly synergistic anthelmintic combination that shows mutual hypersusceptibility. Proc Natl Acad Sci U S A. 2010 Mar 30; 107(13):5955-60.

View in: PubMed

People

Explore

Similar Concepts

Top Journals